|This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education(CSPE). View more NASP/CSPE Activities
In this activity, technicians will learn about the presentation, prevalence, and risk factors for contracting hepatitis C virus (HCV). The workup for HCV requires extensive lab testing to ensure patients receive the most appropriate therapy and for the right length of time. HCV prognosis, goals of therapy, and guideline-recommended treatment options will be discussed. Specialty pharmacies and insurance companies perform drug utilization reviews (DURs) which involve detailed assessments of patient’s lab tests. The technician will be able to anticipate these lab requirements for the successful completion of prior authorizations (PA) and gain awareness on other important workflow considerations.
The target audience for this activity includes pharmacy technicians. Upon completion of this activity, participants will be able to:
- Recognize the presentation, prevalence, and risk factors for the hepatitis C virus (HCV).
- Describe the goals of therapy and prognosis of HCV.
- Outline the current treatment options for HCV.
- Explain the important workflow processes to consider when dispensing medications to treat HCV.
Michelle Abou-Eid, PharmD
Banner Specialty Pharmacy
Amanda Mooney, PharmD
Ochsner Specialty Pharmacy
Claire Ӧzoral, PharmD, BCPS
Ochsner Specialty Pharmacy
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. None of the faculty have any relevant financial and/or commercial relationships to disclose.
Release Date: November 13, 2020
Expiration Date: November 13, 2023
This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-418-H01-T has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.